PBS lists medications to reduce severity of COVID-19 19 July 2022 Medications that reduce the severity of COVID-19 are now available on the Pharmaceutical Benefits Scheme (PBS). Oral anti-viral medications, Paxlovid and Lagevrio, can now be prescribed by doctors or authorised nurse practitioners to people living with any type of diabetes who use medication to manage their condition and have another condition. Other conditions include heart or kidney disease or obesity. People living in residential aged care and all people aged 70 and over are also eligible even if they have no risk factors. The medications can be prescribed for: People 50 years of age or older, with two additional risk factors for developing severe COVID-19People 30 years of age or older identifying as Aboriginal or Torres Strait Islander, with two additional risk factors for developing severe diseasePeople 18 years of age or older, who are moderately to severely immunocompromised. The medicines must be started as soon as possible after a diagnosis of COVID-19. If you have developed COVID-19 please speak to your health team about accessing these medicines immediately. It is important to note anti-viral medicines are not intended to be used as substitutes for getting vaccinated against COVID-19. ºÚÁÏÍø continues to recommend people get vaccinated and boosted in line with the latest advice from the Australian Technical Advisory Group on Immunisation.
News 27 May 2026 Tzield listing a game-changer for early-stage type 1 diabetes The first new therapy for type 1 diabetes in nearly a century, which works to delay the need for insulin therapy in type 1 diabetes, has been approved for use in Australia by the Therapeutic Goods Administration. Continue Reading
Blog 27 May 2026 How diabetes, depression, anxiety, and medicines are connected People with diabetes can be depressed or anxious more often than people without diabetes. Studies show that when you have diabetes, you are almost twice as likely to be depressed, regardless of the type of diabetes. Continue Reading
Media releases 9 May 2026 Research reveals genes may determine who benefits most from popular weight-loss and diabetes medicines New research supported by ºÚÁÏÍø has confirmed that a person’s genes can influence how well widely used diabetes medicines... Continue Reading